Form 4: Clene Inc. Director David J. Matlin Acquires Stock Options

Director David J. Matlin of Clene Inc. was granted stock options for 5,563 shares of common stock at an exercise price of $4.40 per share.

Summary

• David J. Matlin, a director at Clene Inc., was granted stock options to purchase 5,563 shares of common stock.
• The options were granted on December 6, 2024, under the company's Amended 2020 Stock Plan.
• The exercise price for these options is $4.40 per share.
• The options vest immediately upon grant and expire on December 5, 2034.

Sentiment

Score: 7

Explanation: The document reflects a standard practice of granting stock options to a director, which is generally viewed positively as it aligns interests. There are no negative implications.

Positives

• The immediate vesting of the options may incentivize the director to work towards the company's success.
• The grant of options aligns the director's interests with those of the shareholders.

Industry Context

This is a standard practice for incentivizing directors and aligning their interests with the company's performance.

Comparison to Industry Standards

• Stock option grants to directors are a common practice across publicly traded companies.
• The vesting schedule of immediate vesting is not unusual, but can vary by company and role.
• The exercise price of $4.40 is specific to Clene Inc. and would need to be compared to the current market price of the stock to assess its value.

Stakeholder Impact

• The stock option grant may have a positive impact on shareholder confidence by aligning director interests with company performance.

Key Dates

Keywords

stock options, insider trading, beneficial ownership, director, Clene Inc., equity